To unravel the mechanism underlying the tumor-promoting effect of CYP2J2/EpOME in TNBC, we conducted a comprehensive transcriptomics analysis involving 106 disease cohorts and 52 control cohorts (Fig. 5A). The gene discussed is CYP2J2; the disease is neoplasm.